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Moderate therapeutic hypothermia procedures are used in post-cardiac arrest care, while in 30 
surgical procedures, lower core temperatures are often utilized to provide cerebral protection. 31 
Involuntary reduction of core body temperature takes place in accidental hypothermia and 32 
ventricular arrhythmias are recognised as a principal cause for a high mortality rate in these 33 
patients. We assessed both clinical and experimental literature through a systematic literature 34 
search in the PubMed database, to review the effect of hypothermia on cardiac 35 
electrophysiology. From included studies, there is common experimental and clinical 36 
evidence that progressive cooling will induce changes in cardiac electrophysiology. The QT-37 
interval is prolonged and appears more sensitive to decreases in temperature than the QRS-38 
interval. Severe hypothermia is associated with more pronounced changes, some of which are 39 
pro-arrhythmic. This is supported clinically where severe accidental hypothermia is 40 
commonly associated with ventricular fibrillation or asystole. J-waves in human ECG-41 
recordings are regularly but not always observed in hypothermia. Its relation to ventricular 42 
repolarisation and arrhythmias is not obvious. Little clinical data exist on efficacy of anti-43 
arrhythmic drugs in hypothermia, while experimental data show the potential of some agents, 44 
such as the class III antiarrhythmic bretylium. It is apparent that QT-prolonging drugs should 45 








1. Introduction 52 
Hypothermia can be accidental or a therapeutic measure to lower metabolic demands and 53 
protect against hypoxic damage. The impact of hypothermia could be more severe when 54 
comorbidities exist (1). Therapeutic temperature management is used after severe injury or 55 
disease like cardiac arrest. Comatose survivors are cooled to below 36°C, although doubt 56 
have been raised whether more profound cooling is beneficial. Avoiding hyperthermia could 57 
be the principal mechanism for providing neuroprotection in these patients (2). In trauma 58 
patients, hypothermia has a negative impact, giving 3-fold increase in mortality (3).  59 
 60 
The degree of cooling varies greatly between types of accidental or therapeutic exposure. 61 
Based on clinical studies, hypothermia has been classified into 3 broad categories: Mild 35°C 62 
-34°C, moderate 30°C-34°C or severe <30°C (1). The overall mortality of accidental 63 
hypothermia is estimated between 25-40% in most studies (4,5) and arrhythmias are a major 64 
concern both during cooling and rewarming. Submersion and immersion hypothermia deaths 65 
could incorrectly be ascribed to drowning, with patients succumbing to hypothermia induced 66 
arrhythmias or an autonomic conflict. It is hypothesised that ventricular arrhythmia can arise 67 
from a simultaneous activation of the diving response and cold shock; triggering a 68 
parasympathetically driven bradycardia, and sympathetically driven tachycardia (6). 69 
 70 
Detailed measurements of cardiac electrophysiology during hypothermia are challenging to 71 
obtain. Invasive electrical measurements provide higher resolution and more detailed regional 72 
information. Due to these benefits, experimental studies give important information. 73 
However, a large proportion of such studies are carried out at room temperature, thus only 74 
observing electrophysiology at temperatures corresponding to severe hypothermia, without 75 
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comparing findings to normothermic conditions (7-9). It is therefore important to assess 76 
literature that compares electrophysiology at both low and normal core temperatures. Cardiac 77 
electrophysiology is largely species-dependent, with hibernators being resistant to lethal 78 
ventricular fibrillation (10). Comparison and critical review of experimental and clinical 79 
findings is therefore essential for a better understanding of the pro-arrhythmic impact of 80 
hypothermia. 81 
 82 
2. Materials and methods 83 
A systematic literature search was conducted on 27 March 2017 in the electronic PubMed 84 
database. All articles retrieved for: #1 Hypothermia AND electrophysiology, and #2 85 
hypothermia AND ECG, were assessed. 86 
A total of 1412 publications were identified. The main criterion for inclusion was that they 87 
had a hypothermia protocol and a measure of cardiac electrophysiology. Case reports, studies 88 
in children and neonates, studies on non-mammals, studies in which hypothermia was induced 89 
with drugs or local injection of cold fluids, regional cooling of hearts and studies where 90 
cardioplegic solutions were used prior to cooling, were excluded. 91 
Studies were considered for inclusion based on the abstract. If this was inadequate or absent, 92 
the full text was assessed to examine whether they met inclusion criteria. A total of 86 studies 93 
were included, of which 38 were clinical and the remainder were experimental in different 94 
species. Articles that were not detected through the literature search were found in reference-95 
lists of included papers or other literature reviews.   96 
 97 
3. Ventricular action potential and ion-channels (Fig1, table1) 98 
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To initiate an action potential (AP) and subsequent contraction of resting ventricular 99 
cardiomyocytes (phase 4 of the AP), depolarisation must be initiated by increased sodium 100 
conductance via voltage-gated Na+-channels (phase 0). In severe hypothermia (27°C) sodium 101 
current appears impaired (11), thus prolonging phase 0. Phase 1 is initiated by rapid 102 
inactivation of the Na+-channels and activation of a transient outward current (Ito),. This leads 103 
to a transient increase in potassium conductance, causing the rapid and transient repolarisation 104 
seen as the AP notch. Some studies suggest a heterogenic effect of hypothermia on Ito (12) 105 
with a larger epicardial outward potassium current, causing a more prominent epicardial AP 106 
notch (13). Phase 1 is followed by the plateau phase (phase 2), where the membrane potential 107 
is more stable and repolarisation is slowly initiated by opening of delayed rectifier K+-108 
channels, increasing membrane potassium conductance. Simultaneously, calcium influx is 109 
initiated due to opening of L-type Ca2+ channels. In severely hypothermic cardiomyocytes, 110 
the transient calcium influx during phase 2 is prolonged and the cytosolic calcium 111 
concentration is increased (14). During phase 3, the L-type Ca2+ channels close, while the 112 
delayed rectifier K+-channels remains open. Thus, a change in membrane potential to more 113 
negative potentials occurs and which engages the background inwardly rectifying K+ 114 
conductance, contributing to repolarisation of the cardiomyocyte. Both delayed and inward 115 
rectifying K+-channel function appears temperature-sensitive. A reduction in core temperature 116 
will therefore impair potassium channel function and prolong phase 2 and 3 (11,15,16). In 117 
general, ion-channel function is severely affected by hypothermia and studies aiming at 118 
describing normothermic electrophysiology, should not be carried out at room-temperature. 119 
 120 
4. Atrial depolarisation and atrio-ventricular conduction (Fig1, table1) 121 
4.1 Experimental studies 122 
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In ECG-recordings, atrial depolarisation underlies the P-wave, while ventricular 123 
depolarisation underlies the QRS-complex and the PR interval reflects conduction through the 124 
atrio-ventricular (AV) node. PR-interval prolongation can occur in different pathological 125 
situations; typically AV-block (17). In hypothermic dogs the PR-interval became prolonged 126 
after cooling to 29°C (18) and was doubled at 24°C (19). PR-prolongation is smaller in 127 
monkeys, with a 11% - 38% change during cooling to 25°C (20). In hibernating squirrels, 128 
where core temperature fell below 11°C, PR-interval was prolonged by a factor of 7. The T-P 129 
segment (representing diastole) was increased 40-70 times, underlying pronounced 130 
bradycardia (21). While heart rate is decreased, inter-beat interval variability is increased in 131 
hypothermic rat hearts during cooling to 27°C. The authors concluded that this change was 132 
attributed to the sino-atrial (SA) node. Regularity of discharge of pacemaker cells was 133 
impaired by low temperature, while AV conduction appeared unaffected (22). However, in 134 
vivo cooling does produce conduction disturbances spanning from first degree AV block to 135 
total heart block (23-25). In rats, these disturbances present through a sudden increase in PR-136 
interval at 22°C. If rats received respiratory support, such block was delayed to below 18°C. 137 
Subsequently, atrial arrest would occur prior to ventricular arrest (26). In isolated rabbit atria, 138 
arrest occurs after cooling to 21°C (27). 139 
 140 
4.2 Clinical studies 141 
Bradycardia is a well-known effect of cooling, but is not always observed during moderate 142 
hypothermia. 15 accidental hypothermia patients in sinus rhythm, with an average core 143 
temperature of 30.5°C, had heart rates ranging from 13-100 beats/minute (28). A 144 
sympathetically mediated increase second to initial cooling, could contribute to large 145 
variations in heart rate. In sedated patients, subjected to therapeutic hypothermia, bradycardia 146 
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seems more consistent. Patients cooled to a target of 33°C had an average heart rate reduction 147 
of 19 beats/minute (29).  148 
 149 
During cooling to 28°C - 30°C, 7 of 13 patients had prolonged PR-interval (30). Although 150 
some reports find unchanged PR-interval after cooling (31), it is generally increased in 151 
therapeutic hypothermia (29,32-35). Hypothermia-induced PR-prolongation is found in some 152 
(36,37), but not all (38,39) ECG-studies during rewarming from accidental hypothermia. In 153 
severely hypothermic patients, Darocha et al. found low P-wave amplitude (0.1mV) (37), 154 
while Kim et al. found unchanged (0.16 mV) amplitude at 33.5°C (31).  155 
 156 
Serious AV-nodal pathology is not observed in all studies. Only 3 of 25 Scottish accidental 157 
hypothermia patients (mean core temperature: 30.3°C) presented with varying degrees of AV 158 
block (28). In a Brazilian study, AV block was seen in 3 of 59 patients but only 10 patients 159 
had core temperatures below 28°C (36). Severe accidental hypothermia does however 160 
promote AV block (40,41). This relationship is also observed in patients subjected to direct 161 
cardiac cooling (42). 162 
 163 
4.3 Summary 164 
Hypothermia induces bradycardia and prolongs AV nodal conduction, as observed by 165 
elongated PR-interval. Severity can span from first degree AV-block to total heart block and 166 
is dependent on temperature reduction. These effects are demonstrated more clearly below 167 




5. Ventricular depolarisation (Fig1, table1) 170 
5.1 Experimental studies 171 
During hypothermia, reduced conductance of Na+-channels is reflected by reduced maximum 172 
rate of depolarisation in guinea-pig papillary muscle at 27°C (11) and ventricular 173 
depolarisation is slowed in sheep (43). Hypothermia-induced prolongation of depolarisation is 174 
reflected in ECG recordings. In rats, ventricular activation time (QR-time) increased during 175 
progressive cooling to cardiac arrest (44).  176 
 177 
5.2 Clinical studies 178 
QRS duration appears increased in severe accidental and therapeutic hypothermia (33,37). In 179 
moderate hypothermia, there are reports of prolonged QRS duration (31,34) but it is more 180 
often unaffected or decreased (29,38,39,45-47). Lam et al. found an 8 ms (7%) decrease in 181 
QRS interval of 101 cardiac arrest survivors at 33°C, indicating increased endocardial to 182 
epicardial conduction. Interestingly, there was a trend towards non-survivors having shorter 183 
QRS-interval compared to survivors (P<0.1) (29). After cooling to 28°C - 30°C, 7 of 13 184 
patients had prolonged QRS-interval (30).  185 
 186 
5.3 Summary 187 
Progressive cooling slows ventricular depolarisation. This effect appears to be non-linear and 188 
is only consistently observed after cooling below 30°C, which appears to be a threshold 189 
temperature for this effect. Some studies even suggest faster depolarisation during moderate 190 





6. Ventricular repolarisation (Fig1, table1) 194 
6.1 Experimental studies 195 
Lengthening of cardiac repolarisation is a prominent feature of cooling (11). Studies in 196 
isolated cardiomyocytes indicate that both IK and IK1-channels are temperature-sensitive 197 
(11,15,16). Impaired potassium conductance mediates prolonged repolarisation, reflected in 198 
QT-interval of the ECG-signal. In dogs cooled to 34.2°C (48) and rats cooled to cardiac 199 
arrest, QTc-interval was prolonged in a linear relationship with decreasing core temperature. 200 
Cooling-induced QT-prolongation is also observed in rats (44), cats (49) and rabbit hearts 201 
(50). Siems et al. reported that after the initial prolongation of QTc, a threshold was reached, 202 
thereafter no change occurred during further cooling of dogs (51). Further, epicardial mapping 203 
of intact rabbit hearts at 32°C, showed nonuniform repolarisation-changes, which was 204 
particularly pronounced at the left ventricular (LV) apex (52). When studying action potential 205 
duration (APD) in endocardial and epicardial canine LV cells at 26°C, Piktel et al. found 206 
increased (358%) dispersion of repolarisation. At the same temperature, conduction time was 207 
increased by 37%. During rewarming conduction time normalised, while dispersion of 208 
repolarisation remained increased (53). It is also enhanced in hypothermic guinea-pig hearts 209 
(54). 210 
 211 
Repolarisation is more slowed by hypothermia (32°C) in Purkinje fibres than in ventricular 212 
cardiomyocytes. This is thought to found basis for the U-wave, occurring after the T-wave in 213 
ECG-recordings (55). Further, mathematical simulation indicate that prolonged epicardial 214 
APD and unchanged endocardial APD, could explain increased transmural repolarisation 215 
gradient during hypothermia (56). However, in canine right ventricular preparations, phase 1 216 
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epicardial repolarisation is enhanced at 32°C (12). Hibernating hedgehogs that lack a 217 
physiological AP plateau phase seem less vulnerable to hypothermia than guinea-pigs, where 218 
slow conduction and dispersion of repolarisation is more apparent after cooling to 15°C (57). 219 
This could explain why hedgehogs rarely develop VF during hypothermia (58). 220 
 221 
6.2 Clinical studies 222 
Clinical ECG-studies in therapeutic and accidental hypothermia show consistent increased 223 
QTc-interval and thus prolonged repolarisation, mainly without QRS-interval change (29,31-224 
39,45-47,59-63). Prolongation of QTc (64,65) in presence of unchanged QRS-interval is also 225 
found in patients with acquired poikilothermia (average core temperature 33.9°C) (64). Fast 226 
induction of therapeutic hypothermia gives a larger increase in QTc duration than slow 227 
cooling (47) . No relation to increased incidence of arrhythmias or mortality was however 228 
found in a study on therapeutic hypothermia patients (29). Despite this, cooling of patients 229 
with long QT syndrome should be done with great caution (34) as rate of repolarisation 230 
appears more temperature-sensitive than rate of depolarisation. 231 
 232 
T-wave flattening or inversion can also occur during cooling, sometimes in concert with 233 
increased J-wave amplitude (32). Flattening or inversion of T-waves occurred in 8 of 13 234 
patients cooled prior to neurosurgery (30), and was the most common ECG-finding during 235 
duodenal ulcer-treatment with gastric hypothermia (66). 236 
 237 
Increased dispersion of repolarisation is found in animal models after cooling below 32°C 238 
(54,57,67) and is associated with ventricular arrhythmias. In ECG-recordings, the interval 239 
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from peak to end of the T-wave (TpTe), can be used as a marker of transmural dispersion of 240 
repolarisation. Kim et al. did not find any significant change in TpTe after therapeutic cooling 241 
of patients to 33.5°C (31). In accidental hypothermia patients however, increased QTc 242 
dispersion was found (38). 243 
 244 
6.3 Summary 245 
Cardiac repolarisation is prolonged with an approximately linear relationship with decreasing 246 
core temperature, and is evident during early cooling. This is basis for the consistent QTc-247 
prolongation observed in both therapeutic and accidental hypothermia in humans.   248 
 249 
 250 
7. J-wave  (Fig1, table1) 251 
The J-wave is a hypothermia-associated deflection between the end of the QRS complex and 252 
the beginning of the ST segment. Although first described by Tomaszewski in 1938 (68,69), it 253 
is often named the Osborn-wave, after an experimental dog study from 1953. The appearance 254 
of a J-wave at 25°C was described as “a current of injury” and correlated to the later onset of 255 
VF (70), a finding that was supported by Boba (71).  256 
 257 
7.1 Experimental studies 258 
Temperature of onset and proportion of animals that develop J-waves varies between studies. 259 
Siems et al. described the J-wave as Ta and reported occurrence in 9 of 28 cooled dogs at a 260 
mean core temperature of 31.6°C (51). Epicardial cooling of dogs resulted in J-waves at 261 
29.7°C (72) and at 27°C in dogs immersed in an ice-bath. Authors related this with a net loss 262 
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of myocardial potassium (73). In transmural, canine wedge-preparations, hypothermia-263 
induced J-waves is associated with a prominent AP notch only in the epicardium. This 264 
suggests a heterogeneous distribution of transient outward current (Ito) that underlies the 265 
occurrence of J-waves (13). Findings from Morita et al. concur with this theory, as blocking 266 
of Ito with 4-aminopyridine, reduced J-wave elevation at 32°C (12). In a canine wedge 267 
preparation model, J-waves were increased during cooling to 32°C. Simulating early 268 
repolarisation syndrome during hypothermia, accentuated the epicardial AP notch (74).  269 
 270 
7.2 Clinical studies 271 
The proportion of hypothermic patients presenting with J-waves varies greatly between 272 
studies and is temperature dependent. J-waves occured in 100% of patients with core 273 
temperatures below 32°C (76) or 30°C (75). This is in accordance with a study on induced 274 
hypothermia prior to surgery. 9 of 60 patients developed J-waves, which with one exception, 275 
was first observed after cooling below 30°C (71). A temperature-dependent relationship is not 276 
clear in all accidental hypothermia studies. Darocha et al. found J-waves in only 3 of 19 277 
patients with core temperatures below 26.2°C (37) and Duraković showed that >70% of 278 
elderly patients presented with J-waves both at temperatures between 32°C - 35°C and below 279 
32°C (38,63).  280 
 281 
Vectorcardiographic recordings show the three-dimensional direction of electrical conduction 282 
in the heart. After cooling, a J-loop deflection related to J-wave occurrence appeared in 5 283 
therapeutic (30,5°C-31,5°C) (77) and 23 accidental hypothermia patients (22.8°C–34.4°C) 284 
(78). Further, J-wave amplitude seems inversely correlated with core temperature-reduction 285 
(36,76,79), but an association with ventricular arrhythmias is not supported by all clinical 286 
13 
 
studies. In 30 accidental hypothermia patients (29.4°C–33.5°C) with J-waves, only one 287 
developed ventricular tachycardia (VT) (75) and J-waves does not predict survival chance 288 
(39). A multi-centre study from South Korea observed J-waves in 41% of therapeutic 289 
hypothermia patients, while VF only occurred in 1.7% (80), which concurs with other studies 290 
(81). J-waves are more common in hypothermic STEMI (38.6%) than non-STEMI (15.2%) 291 
patients (45). Further, Williams et al. reported that early repolarisation and J-waves are more 292 
common in survivors of idiopathic (100%) than coronary artery disease-associated ventricular 293 
fibrillation (66.7%) (82). This reflects on underlying differences in cardiac pathophysiology 294 
and necessitates careful cooling of patients vulnerable to early repolarisation. 295 
 296 
7.3 Summary 297 
The likely cause of the J-wave is late and slow depolarisation of a significant region of the 298 
ventricle immediately after the QRS complex, or conversely an early repolarisation of an area 299 
of the ventricle. Both cases create an area of the ventricle that is polarised relative to the 300 
remainder. In both human and experimental studies, the occurrence of J-waves, and the 301 
temperatures at which it arises, varies greatly. Although postulated by Osborne (70), there is 302 
apparently no consistent relationship between presence of J-waves and risk for ventricular 303 
arrhythmias during hypothermia. 304 
 305 
8. Incidence of Arrhythmias during cooling (table1) 306 
8.1 Experimental studies 307 
During progressive cooling of 15 dogs, cardiac arrest occurred after ventricular fibrillation 308 
(VF) in 60% of animals (51). During VF, cooling does not affect intramyocardial voltage (83) 309 
but VF morphology is changed (84). Further, compared to at 37°C and 30°C, spiral wave 310 
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excitations are more disorganised at 33°C. Optical mapping showed that such disorganisation 311 
favoured spiral wave collision and self-termination of VT/VF (85). These findings concur 312 
with pig experiments showing that successful defibrillation from VF was achieved more often 313 
at 33°C, than at 30°C or 37°C (86). Cooling to 30°C however, enhanced epicardial APD 314 
dispersion, wavebreaks and re-entry, thus increasing the vulnerability to pacing-induced VF 315 
(87), similar to studies in other dog (88) and pig models (89). Reduced VF-threshold is found 316 
in concert with electrical alternans, detected in both QRS-complex and T-waves (90,91).  317 
 318 
VF-risk appears dependent on cooling method. Smith et al. investigated whether hemodilution 319 
during therapeutic hypothermia could be beneficial. They showed that rapid cooling to 20°C 320 
in non-hemodiluted dogs resulted in cardiac arrest in 50% of animals (92), similar to findings 321 
of Wynne et al (93). In dogs hemodiluted with 50% of their calculated blood volume replaced 322 
by Ringer’s lactate solution, cardiac arrest (VF) occurred in only 5% (92). Rapid and 323 
profound cooling could however also terminate VF in vitro, as found by Chorro et al. in rabbit 324 
hearts that were perfused with cold (4°C), oxygenated Tyrode’s solution (94). Cardiac 325 
vulnerability is promoted further by rewarming. In canine wedge preparations cooled to 26°C, 326 
VF and VT was more frequent during rewarming than cooling (53). In a similar model, 327 
simulating early repolarisation syndrome, hypothermia (32°C) caused local re-excitation and 328 
polymorphic VT/VF (74).  329 
 330 
Development of VF during hypothermia and rewarming could be triggered by adrenergic 331 
stimuli. In a feline model of hypothermia, ventricular arrhythmias were triggered in 100% of 332 
hearts when adrenaline, noradrenaline or isoprenaline were provided at 21°C, in doses that 333 




8.2 Clinical studies 336 
Risk for ventricular arrhythmias is dependent of severity of hypothermia and pose a 337 
significant challenge during rewarming. Of 19 accidental hypothermia patients, admitted with 338 
core temperatures between 16.9°C–29°C, 7 were in ventricular fibrillation, while 2 presented 339 
with asystole (37). In a Japanese study of 60 patients however, no patients with a core 340 
temperature above 26°C had VF (96). In urban accidental hypothermia, underlying conditions 341 
and substance abuse can be as important predisposing factors for cardiac arrest as core 342 
temperature (61). In therapeutic hypothermia, ventricular ectopic activity is increased (97) and 343 
non-sustained VT can occur frequently (34), but sustained ventricular arrhythmias are 344 
uncommon in most (34,35,45,62,80) but not all studies. Mirzoyev found polymorphic VT in 345 
11.7% of therapeutic hypothermia patients. VT onset occurred at an average of 34.7°C during 346 
cooling in patients that were hypokalaemic and had QTc interval-prolongation (46). When VF 347 
is induced during cooling prior to coronary surgery, fibrillation frequency is significantly 348 
higher if induced at 34°C, compared to at 30°C. Further, Strohmenger et al. found that 349 
defibrillation success increased if fibrillation frequency was allowed to increase above 5 Hz, 350 
prior to counter-shock attempts during rewarming (98). 351 
 352 
Atrial fibrillation (AF) is reported to have high incidence in several accidental (61,63,76,99) 353 
and therapeutic hypothermia studies (34,45). Some reports suggest otherwise, most notably in 354 
a recent study where only 2 of 59 accidental hypothermia patients presented with AF (36). 355 
Like ventricular arrhythmias, onset appears temperature-dependent. In a study from Tokyo, 1 356 
of 18 accidental hypothermia patients with core temperature above 32°C and 23 of 42 patients 357 
with temperatures below 32°C presented with AF (96). During therapeutic cooling in 358 
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preparation for neurosurgery, AF occurred at a mean temperature of 28.9°C (32). Graham et 359 
al. associated onset of AF during accidental hypothermia with a poor prognosis, as 60% of 360 
patients presenting with this rhythm died (39). Earlier findings are conflicting. In 25 patients 361 
cooled for cardiac surgery, mortality rate was 29% when AF was observed, compared to 75% 362 
in patients in sinus rhythm (100).   363 
 364 
8.3 Summary 365 
Vulnerability for ventricular arrhythmias in animal models seem dependant on cooling 366 
method and is promoted by adrenergic stimuli. In humans, VF or asystole is more common in 367 
accidental hypothermia patients admitted with low core temperatures. Serious ventricular 368 
arrhythmias are uncommon in therapeutic hypothermia. 369 
 370 
 371 
9. Pharmacological treatment 372 
Few clinical studies have examined the properties of antiarrhythmic agents during 373 
hypothermia and rewarming. Although limited, most evidence is provided by preclinical 374 
studies using various species. 375 
 376 
9.1 Class I antiarrhythmic agents 377 
Quinidine is a class I antiarrhythmic agent and blocks voltage-gated Na+-channels. It also 378 
blocks Ito, which prevents loss of AP dome during cooling to 32°C in canine wedge 379 
preparations. Thus, in presence of this pathophysiological substrate for re-excitation and 380 
phase 2 re-entry during hypothermia, quinidine prevented development of VT/VF (74). 381 
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Another Na+-channel blocker; procainamide prolonged PR- and QT-intervals during cooling 382 
in dogs and evaluation of its antiarrhythmic effect was inconclusive (101). 383 
 384 
9.2 Class III antiarrhythmic agents 385 
Bretylium possess antiadrenergic activity through sympathetic ganglion blockade. It is also a 386 
K+-channel blocker. On the hypothesis that cooling would promote ventricular arrhythmias 387 
through increased adrenergic activity, effects of bretylium were studied during rewarming 388 
from 25°C in dogs. Although plasma catecholamine levels remained unchanged, bretylium 389 
increased VF-threshold (102). The same antiarrhythmic effects are found after cooling to 390 
27°C (103) and during rewarming from 24°C (104). However, these positive effects of 391 
bretylium might be limited to preventive treatment. Antiarrhythmic effects were not found 392 
during rewarming of dogs in VF. In the latter study, defibrillation was attempted following 10 393 
min of CPR following drug administration at 22°C, the animals were not actively rewarmed 394 
before defibrillation (105). At such temperatures, defibrillation is challenging independent of 395 
treatment (106).  396 
 397 
Amiodarone has diverse effects, among them is K+-channel blockade and it therefore prolongs 398 
repolarisation. In amiodarone-treated dogs with VF at 22°C, 1/10 were successfully 399 
resuscitated. Resuscitation rate was 4/10 in bretylium treated, and 3/10 in placebo-treated 400 
animals (105). This indicates that pharmacological APD prolongation during hypothermia is 401 
unfavourable. A study on K+-channel blocker sotalol gave the same outcome; sotalol-402 
treatment was more effective in prolonging APD during hypothermic than normothermic 403 




9.3 Class IV antiarrhythmic agents 406 
The class IV antiarrhythmic agent diltiazem is a Ca2+-channel blocker which shortens APD. 407 
Bjørnstad et al. found a progressive AP prolongation during cooling to 25°C, in concert with 408 
reduced VF-threshold. Addition of diltiazem failed to increase VF-threshold in hypothermic 409 
dogs. At 27°C, the Ca2+-channel blocker nisoldipine also shortened APD to within 410 
normothermic values in isolated guinea-pig papillary muscle (108).  411 
 412 
9.4 Other pharmacological agents 413 
In an early repolarisation syndrome model, phosphodiesterase III inhibitors milrinone and 414 
cilostazol were used to increase cAMP and thus augment the inward Ca2+ current (Ica), which 415 
prevented phase 2 re-entry and VT/VF during cooling to 32°C (74). In intact cardiomyocytes, 416 
dopamine will also increase cAMP through β-receptor stimulation. In excised muscle strips 417 
from pig ventricular septum, dopamine prolonged APD at 32°C (109). Regulation of Ca2+-418 
homeostasis could therefore be promising in treatment of hypothermia-induced arrhythmias. 419 
In a canine model of hypothermia, dipyridamole is thought to mediate such effect (110) and 420 
reduced the core temperature of which dogs would go into VF (111). 421 
 422 
Fluid treatment with low or high molecular weight dextran did not have any effect on the 423 
ECG of dogs cooled to 20°C-22°C (112). Further, benzodiazepines such as diazepam produce 424 
Ca2+-channel blockade and has been tested in a guinea-pig model of hypothermia, to explore 425 
potential anti-arrhythmic effect. However, significant shortening of APD was only obtained 426 
by a 100µM dose and the effect was subtle compared to the Ca2+ channel blocker nisoldipine. 427 
It was therefore concluded that diazepam has little clinical potential in prevention of 428 




9.5 Summary 431 
Little information on the effect of antiarrhythmic treatment exists from clinical hypothermia 432 
studies, but preclinical reports suggest favourable properties of some drugs. Quinidine and 433 
other Na+-channel blockers could prevent VF by inhibiting hypothermia-induced phase 2 re-434 
entry. Further, bretylium prevents VF in dogs suffering severe hypothermia, probably 435 
attributed to its antiadrenergic effects. 436 
 437 
10. Conclusion and clinical recommendations 438 
The impact of hypothermia on cardiac electrophysiology largely depends on the extent of 439 
cooling and resultant core temperature. Severe cooling generates more profound changes as 440 
reported in both clinical and experimental studies. Interestingly, the observed changes are not 441 
uniform. In clinical studies, prolongation of QT-interval is observed during cooling to 442 
moderate therapeutic hypothermia, while the temperature-dependent effects on QRS- and PR-443 
interval are inconsistent. Accordingly, repolarisation seems more vulnerable to smaller 444 
changes in temperature. Experimental studies reflect these findings and show a heterogenic 445 
prolongation of repolarisation both on the epicardial surface and transmurally during 446 
hypothermia, while depolarisation seems largely unaffected during initial cooling.  447 
 448 
Efforts to provide evidence-based information for anti-arrhythmic treatment during 449 
hypothermia and rewarming is largely derived from experimental models. The underlying, 450 
heterogenic effect of moderate hypothermia; i.e. cardiac depolarisation largely unaffected by 451 
cooling, while repolarisation is prolonged, could be a pro-arrhythmic substrate that is 452 
worsened by QT-prolonging drugs. Consequently, treatment of accidental hypothermia 453 
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patients and use of therapeutic hypothermia is complicated by drugs of non-cardiac indication 454 
that prolong the QT-interval, e.g. a wide range of antidepressants, antipsychotics, antibiotics 455 
and methadone (113).  456 
 457 
On this background, it is vital to monitor cardiac electrophysiology closely in hypothermic 458 
patients. Administering cardioactive drugs should be carried out with great caution during 459 
rewarming. Medication that prolongs repolarisation (increases QT-interval) or promotes 460 
cardiac excitation should largely be avoided in accidental hypothermia-patients in sinus 461 
rhythm. Before and during therapeutic hypothermia, clinicians should consider dose-reduction 462 
of such drugs. Monitoring their serum concentrations during prolonged therapeutic 463 
hypothermia is indicated, as drug metabolism is altered by cooling, increasing the risk for 464 
cardiotoxic effects. Further, the profound absence of experimental and clinical evidence for 465 
anti-arrhythmic treatment in hypothermic patients, yields a demand for translational and 466 
clinical studies to lay foundation for clinical guidelines.  467 
 468 
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Figure and table legends 753 
 754 
Figure 1: A schematic drawing of a human action potential (AP) and ECG-signal during 755 
normothermia and hypothermia. Reduction of core temperature appears to have a heterogenic 756 
effect of depolarisation (phase 0 of the AP and QRS-interval of the ECG) and repolarisation 757 
(phase 2-3 of the AP and QT-interval of the ECG). During moderate hypothermia 758 
depolarisation is largely unaffected or shortened, while repolarisation is prolonged. In severe 759 
hypothermia, both depolarisation and repolarisation is prolonged. Several ECG-findings could 760 
be found in hypothermic patients and are reflected in the AP. Dispersion of beat-to-beat QT-761 
interval indicated dispersed repolarisation, while appearance of J-waves during hypothermia 762 
could be caused by a transmural heterogenity in phase 1 repolarisation, with a large epicardial 763 
notch.  764 
 765 
Table 1: General electrophysiological findings during mild and moderate (>30°C) and severe 766 
hypothermia (<30°C) 767 
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